emerging glp-1 gip weight loss treatments 2025 A network meta-analysis backed weight-loss benefits with several receptor agonists, with less certainty for newer-generation agents. Read more at the link in bio The Clinical Application of GLP-1RAs

DY Patil College of Pharmacy, India

Over time, data from secondary and exploratory objectives of large randomized controlled-trials suggested that GLP1-RAs could also exert renal action by slowing the progression of kidney disease in patients with and without diabetes

We expect that a large number of these patients could switch to branded versions, helping the near-term growth trajectory for the current incumbents

The bioavailability of orally swallowed GLP-1 peptides sits between 0.4% and 1% without special absorption enhancers

Thats why Clayas platform includes virtual consultations with licensed medical providers, customized meal plans and exercise recommendations, a private wellness community for peer support, and personalized progress tracking through the Claya app